TY - JOUR
T1 - Medical marijuana use in Connecticut
AU - Roginiel, Aliya C.
AU - Gopal, Anand D.
AU - Parikh, Ravi
AU - Ross, Joseph S.
AU - Del Priore, Lucian V.
AU - Teng, Christopher C.
N1 - Funding Information:
Acknowledgments: Funding/support and role of the sponsor: Ms. Roginiel received a student research grant provided by the Yale School of Medicine Office of Student Research under NIH training grant award T35DK104689. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors assume full responsibility for the accuracy and completeness of the ideas presented.
PY - 2018/2
Y1 - 2018/2
N2 - Objective: The Connecticut Medical Marijuana Program (MMP) was approved in 2012, allowing for the legal use of marijuana under specific indications. Tis study describes the use of medical marijuana in CT, using data as of May 2017. Methods: Data were gathered from the CT MMP. We characterized medical marijuana use by county, by indication, and by physician certification of registrants for medical marijuana. Results: Medical marijuana registrants comprised 0.5% (N = 18 118/3 590 886) of the CT population. The most frequent indications for medical marijuana were posttraumatic stress disorder (PTSD) (41.4%, N = 7503/18 118) and damage to the spinal cord with indication of intractable spasticity (20.2%, N = 3668/18 118). A small percentage (4.9%, N = 689/14 138) of CT physicians were registered to certify patients. Conclusion: Medical marijuana registrants made up less than 1% of the CT population. Few physicians were registered to certify patients. Over half of registrants used marijuana for PTSD or for damage to the spinal cord with indication of intractable spasticity.
AB - Objective: The Connecticut Medical Marijuana Program (MMP) was approved in 2012, allowing for the legal use of marijuana under specific indications. Tis study describes the use of medical marijuana in CT, using data as of May 2017. Methods: Data were gathered from the CT MMP. We characterized medical marijuana use by county, by indication, and by physician certification of registrants for medical marijuana. Results: Medical marijuana registrants comprised 0.5% (N = 18 118/3 590 886) of the CT population. The most frequent indications for medical marijuana were posttraumatic stress disorder (PTSD) (41.4%, N = 7503/18 118) and damage to the spinal cord with indication of intractable spasticity (20.2%, N = 3668/18 118). A small percentage (4.9%, N = 689/14 138) of CT physicians were registered to certify patients. Conclusion: Medical marijuana registrants made up less than 1% of the CT population. Few physicians were registered to certify patients. Over half of registrants used marijuana for PTSD or for damage to the spinal cord with indication of intractable spasticity.
UR - http://www.scopus.com/inward/record.url?scp=85041732408&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85041732408
SN - 0010-6178
VL - 82
SP - 69
EP - 74
JO - Connecticut Medicine
JF - Connecticut Medicine
IS - 2
ER -